Skip to content

A prospective, randomized, controlled clinical study of unibody flexible and rigid ureterorenoscope and ureteroscopy in the treatment of proximal incarcerated ureteral calculi (<=3cm)

A prospective, randomized, controlled clinical study of unibody flexible and rigid ureterorenoscope and ureteroscopy in the treatment of proximal incarcerated ureteral calculi (<=3cm)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058279
Enrollment
Unknown
Registered
2022-04-04
Start date
2022-04-06
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Calculi

Interventions

Experimental group:unibody flexible and rigid ureterorenoscope
Control group:ureterorenoscope

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Adult patients aged >18 years and <70 years; 2. After the diagnosis of B ultrasound, CT, kindneys urerter bladder (KUB) and/or intravenous pyelography (IVP), the maximum diameter of the calculi measured by CT was more than or equal to 0.8 cm; 3. Ureteral calculi located below the ureteropelvic junction and above the lower margin of the fourth lumbar vertebrae, staying in the same place for at least 4 weeks and causing ureteral obstruction; 4. Unable to ESWL or refuse ESWL; 5. No urinary tract infection or urinary tract infection has been controlled.

Exclusion criteria

Exclusion criteria: 1. Patients with systemic hemorrhagic diseases; 2. Patients with serious internal diseases, such as arteriovenous thrombosis, stroke history and major organ insufficiency, who cannot tolerate surgery; 3. Patients with ureteral stricture; 4. Patients with severe hydronephrosis secondary infection or pyonephrosis with ipsilateral kidney stones requiring concurrent treatment; Patients with bilateral upper urinary tract stones requiring intervention; 5. Patients with a history of ipilateral ureteral surgery; 6. Pregnant patients; 7. Other patients that should not be included in the research group, such as patients with tumors, mental disorders, and patients in the infectious disease period, which may lead to serious adverse consequences.

Design outcomes

Primary

MeasureTime frame
Stone removal rate;Operation success rate;Operation time;Stage 2 surgery rate;Ureteral injury;Postoperative mean recovery time of intestinal function;Number of painkillers used;Postoperative recovery time;Hospitalization costs;

Countries

China

Contacts

Public ContactLi Zaishang

Shenzhen People's Hospital

dean2011@163.com+86 15915720056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026